首页 > 市场调查报告书 > 医疗设备

药物递输设备抛弃式

预填充式注射器市场规模、份额和成长分析（按类型、材质、应用、通路和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902917

预填充式注射器市场规模、份额和成长分析（按类型、材质、应用、通路和地区划分）－2026-2033年产业预测

Prefilled Syringes Market Size, Share, and Growth Analysis, By Type (Disposable, Reusable), By Material (Glass, Plastic), By Application, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 274 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球预填充式注射器市场规模预计在 2024 年达到 75.2 亿美元，从 2025 年的 83.2 亿美元成长到 2033 年的 186.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 10.6%。

随着製药业寻求高效便捷的给药解决方案，全球预填充式注射器市场正经历快速成长。随着人们对自我护理的日益关注，预填充式注射器的便利性和易用性预计将显着提升市场需求，尤其是在避孕药和慢性病管理方面。糖尿病和关节炎盛行率的不断上升，以及生物相似药的推广，进一步推动了已开发市场的发展动能。此外，气喘等疾病的高发生率也凸显了人们对便利治疗方案的需求。随着医疗保健消费者越来越重视自我给药和安全性，预填充式注射器预计将在给药领域占据越来越大的市场份额。

推动全球预填充式注射器市场发展的因素

糖尿病和类风湿性关节炎等慢性疾病的增加显着提高了疫苗的需求，而疫苗主要透过注射给药。注射液需求的激增直接促进了预填充式注射器的普及。这些注射器具有多项优势，例如透过可控包装来提高安全性，降低污染风险并最大限度地减少剂量误差，使其成为疫苗和治疗药物给药的首选。因此，对高效给药系统的日益依赖正在推动预填充式注射器市场的扩张。

全球预填充式注射器市场限制因素

全球预填充式注射器市场面临许多挑战，主要源自于其严苛的生产流程。与传统注射器不同，预填充式注射器需要完善的品质保证系统和严格的监管标准，以确保无菌性、精确剂量和病人安全。此外，不同地区监管准则的差异可能会延长核准时间，并增加製造商的生产成本。这些因素可能阻碍市场成长，限制产品可近性，为该领域致力于提供安全有效医疗解决方案的企业设置了重大障碍。

全球预填充式注射器市场趋势

随着製药公司日益重视包装的安全性和耐用性，全球预填充式注射器市场正经历着向聚合物基解决方案的显着转变。儘管玻璃因其优异的化学相容性而一直是传统上的主流选择，但环烯烃聚合物（COP）和环烯烃共聚物（COC）的应用正日益广泛。这些聚合物材料对于生物製药和复杂药物尤其具有吸引力，因为它们不仅强度高，还能降低玻璃破损带来的污染风险。这一趋势表明，人们越来越关注能够增强产品完整性并满足医疗保健行业不断变化的需求的创新材料。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Becton, Dickinson and Company（BD）（USA）
Gerresheimer AG（Germany）
Schott AG（Germany）
Baxter International Inc.（USA）
Cardinal Health, Inc.（USA）
Terumo Corporation（Japan）
West Pharmaceutical Services, Inc.（USA）
Nipro Corporation（Japan）
Ompi（Italy）
SGD Pharma（France）
Stevanato Group（Italy）
Medtronic plc（Ireland）
Fresenius Kabi AG（Germany）
Ypsomed Holding AG（Switzerland）
ARaymondlife SAS（France）
Credence MedSystems, Inc.（USA）
Nemera（France）
Taisei Kako Co., Ltd.（Japan）
Weigao Group（China）
Braun Melsungen AG（Germany）

结论与建议

简介目录

Product Code: SQSG35B2013

Global Prefilled Syringes Market size was valued at USD 7.52 Billion in 2024 and is poised to grow from USD 8.32 Billion in 2025 to USD 18.62 Billion by 2033, growing at a CAGR of 10.6% during the forecast period (2026-2033).

The global market for pre-filled syringes is experiencing rapid growth as the pharmaceutical sector seeks efficient and user-friendly medication delivery solutions. With an increasing emphasis on self-care, the demand for pre-filled syringes is anticipated to rise significantly due to their convenience and ease of use, particularly in administering contraceptives and managing chronic conditions. The growing prevalence of diabetes and arthritis, coupled with the expansion of biosimilars, further fuels market momentum in developed markets. Additionally, the high incidence of conditions like asthma highlights the need for accessible treatment options. As healthcare consumers continue to prioritize self-administration and safety, pre-filled syringes are poised to capture a larger share of the medication delivery landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Prefilled Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Prefilled Syringes Market Segments Analysis

Global Prefilled Syringes Market is segmented by Type, Material, Application, Distribution Channel and region. Based on Type, the market is segmented into Disposable and Reusable. Based on Material, the market is segmented into Glass and Plastic. Based on Application, the market is segmented into Vaccines and immunizations, Anaphylaxis, Rheumatoid Arthritis, Diabetes, Autoimmune diseases, Oncology and Others. Based on Distribution Channel, the market is segmented into Hospitals, Mail Order Pharmacies and Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Prefilled Syringes Market

The rising prevalence of chronic conditions, including diabetes and rheumatoid arthritis, has significantly heightened the need for vaccines, predominantly delivered via injections. This surge in demand for injectable solutions has directly contributed to the increasing popularity of prefilled syringes. These syringes offer several advantages, such as enhanced safety through controlled packaging that lowers contamination risks and minimizes dosing errors, establishing them as a preferred choice for administering vaccines and therapeutics. Consequently, this growing reliance on efficient delivery systems is propelling the expansion of the market for prefilled syringes.

Restraints in the Global Prefilled Syringes Market

The Global Prefilled Syringes market faces several challenges stemming from the stringent manufacturing processes required for these products. Unlike traditional syringes, pre-filled syringes necessitate robust quality assurance systems and compliance with rigorous regulatory standards to guarantee sterility, precise dosing, and overall patient safety. Furthermore, the need for adherence to varying regulatory guidelines across different regions can result in extended approval timelines and elevated production costs for manufacturers. These factors may hinder market growth and limit accessibility, presenting significant hurdles for companies operating within this sector while striving to deliver safe and effective medical solutions.

Market Trends of the Global Prefilled Syringes Market

The Global Prefilled Syringes market is experiencing a notable shift towards polymer-based solutions, as pharmaceutical companies increasingly prioritize safety and durability in their packaging options. Traditionally dominated by glass, which offers excellent chemical compatibility, the market is now witnessing a rise in the adoption of cyclic olefin polymers (COP) and cyclic olefin copolymers (COC). These polymeric materials are not only stronger but also mitigate the risk of contamination associated with glass breakage, making them particularly appealing for biologics and complex pharmaceuticals. This trend highlights a growing commitment to innovative materials that enhance product integrity and meet the evolving demands of the healthcare sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Raw Material Analysis

Global Prefilled Syringes Market Size by Type & CAGR (2026-2033)

Market Overview
Disposable
Reusable

Global Prefilled Syringes Market Size by Material & CAGR (2026-2033)

Market Overview
Glass
Plastic

Global Prefilled Syringes Market Size by Application & CAGR (2026-2033)

Market Overview
Vaccines and immunizations
Anaphylaxis
Rheumatoid Arthritis
Diabetes
Autoimmune diseases
Oncology
Others

Global Prefilled Syringes Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospitals
Mail Order Pharmacies
Ambulatory Surgery Centers

Global Prefilled Syringes Market Size & CAGR (2026-2033)

North America (Type, Material, Application, Distribution Channel)
- US
- Canada
Europe (Type, Material, Application, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Material, Application, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Material, Application, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Material, Application, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schott AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ompi (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGD Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stevanato Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARaymondlife SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Credence MedSystems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemera (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taisei Kako Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Weigao Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments